ALK
Alaska Air Group Inc.
$43.73
+$2.38(+5.77%)
42
Overall
60
Value
27
Tech
39
Quality
Market Cap
$4.98B
Volume
2.42M
52W Range
$33.03 - $65.88
Target Price
$57.80
Company Overview
| Mkt Cap | $4.98B | Price | $43.73 |
| Volume | 2.42M | Change | +5.77% |
| P/E Ratio | 49.8 | Open | $42.77 |
| Revenue | $14.2B | Prev Close | $41.34 |
| Net Income | $100.0M | 52W Range | $33.03 - $65.88 |
| Div Yield | N/A | Target | $57.80 |
| Overall | 42 | Value | 60 |
| Quality | 39 | Technical | 27 |
No chart data available
About Alaska Air Group Inc.
Alaska Air Group, Inc., through its subsidiaries, operates airlines. It operates through three segments: Alaska Airlines, Hawaiian Airlines, and Regional. The company offers scheduled air transportation services on Boeing jet aircraft for passengers and cargo in the United States, and in parts of Canada, Mexico, Costa Rica, Belize, Guatemala, and the Bahamas; and for passengers across a shorter distance network within the United States, Canada, and Mexico. Alaska Air Group, Inc. was founded in 1932 and is based in Seattle, Washington.
Sector: Industrials
Industry: Airlines
Latest News
Analysts’ Top Healthcare Picks: Gilead Sciences (GILD), Alkermes (ALKS)
Brian Anderson•3 hours ago
Alkermes Shareholders Approve Amended Stock Incentive Plan
TipRanks Auto-Generated Newsdesk•6 days ago
Analysts Conflicted on These Materials Names: Alkane Resources Ltd (OtherALKEF) and PLS Group (OtherPILBF)
Brian Anderson•8 days ago
Alkermes Advances Phase 3 Narcolepsy Study With ALKS 2680, Adding a New Catalyst to Its Pipeline
TipRanks Clinical-Trials-Auto-Generated Newsdesk•11 days ago
Analysts’ Top Healthcare Picks: Allogene Therapeutics (ALLO), Evommune, Inc. (EVMN)
Brian Anderson•13 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ALK | $43.73 | +5.8% | 2.42M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |